Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lupus

Showing results (1-10 of 6,541) with videos related to

Pageof 655
Sort By:
Lupus|September 4, 2001
Can B cell epitopes of 60 kDa Ro distinguish systemic lupus erythematosus from Sjögren's syndrome?A N Scofield, B T Kurien, T P Gordon, et al.
Lupus|September 4, 2001
Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activityA M Jacobi, W Rohde, M Ventz, et al.
Lupus|September 4, 2001
Antiphospholipid antibody levels in intravenous immunoglobulin (IVIg) preparationsY Sherer, R Wu, I Kraus, et al.
Lupus|September 4, 2001
Chorioretinopathy and discoid plaque-like lesions of the eyelids as useful indicators of systemic lupus erythematosus (SLE) progressionM P Paroli, D Riso, M Pinca, et al.
Lupus|March 13, 2001
CD40 ligand--an important target for immunotherapy?M L Huggins, I Todd, R J Powell
Lupus|March 13, 2001
Induction of anti-DNA antibodies: commentary on article by Satake et alD Isenberg, D Katz, P Maddison, et al.
Lupus|March 13, 2001
Long-term anti-CD154 dosing in nephritic mice is required to maintain survival and inhibit mediators of renal fibrosisS L Kalled, A H Cutler, J L Ferrant
Lupus|July 4, 2001
Double trouble: are lupus and malignancy associated?R Ramsey-Goldman, A E Clarke
Lupus|July 4, 2001
Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled studyR A Levy, V S Vilela, M J Cataldo, et al.
Lupus|July 4, 2001
Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosusS C Bae, H K Koh, D K Chang, et al.
Pageof 655

Showing results (1-10 of 6,541) with videos related to

Sort By:
Pageof 655
Lupus|September 4, 2001
Can B cell epitopes of 60 kDa Ro distinguish systemic lupus erythematosus from Sjögren's syndrome?A N Scofield, B T Kurien, T P Gordon, et al.
Lupus|September 4, 2001
Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activityA M Jacobi, W Rohde, M Ventz, et al.
Lupus|September 4, 2001
Antiphospholipid antibody levels in intravenous immunoglobulin (IVIg) preparationsY Sherer, R Wu, I Kraus, et al.
Lupus|September 4, 2001
Chorioretinopathy and discoid plaque-like lesions of the eyelids as useful indicators of systemic lupus erythematosus (SLE) progressionM P Paroli, D Riso, M Pinca, et al.
Lupus|March 13, 2001
CD40 ligand--an important target for immunotherapy?M L Huggins, I Todd, R J Powell
Lupus|March 13, 2001
Induction of anti-DNA antibodies: commentary on article by Satake et alD Isenberg, D Katz, P Maddison, et al.
Lupus|March 13, 2001
Long-term anti-CD154 dosing in nephritic mice is required to maintain survival and inhibit mediators of renal fibrosisS L Kalled, A H Cutler, J L Ferrant
Lupus|July 4, 2001
Double trouble: are lupus and malignancy associated?R Ramsey-Goldman, A E Clarke
Lupus|July 4, 2001
Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled studyR A Levy, V S Vilela, M J Cataldo, et al.
Lupus|July 4, 2001
Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosusS C Bae, H K Koh, D K Chang, et al.
Pageof 655